Skip to content

Trail Making Test (Chinese version) Used by Chinese Elderly Patients with Mild Cognitive Impairment and Mild Alzheimer' Dementia

Trail Making Test (Chinese version) Used by Chinese Elderly Patients with Mild Cognitive Impairment and Mild Alzheimer' Dementia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017810
Enrollment
Unknown
Registered
2018-08-16
Start date
2018-08-13
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer disease

Interventions

Gold Standard:Trail Making Test A
Index test:Trail Making Test B

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: Meet with 2011 NIA-AA diagnostic criteria: 1. the normal control group(NC): using clinical dementia rating scale (CDR) to measure subjects' memory, direction, judgment and problem solving skills, social affairs, family life, hobbies, CDR =0. MCI group(MCI): using CDR to measure subjects' memory, direction, judgment and problem solving skills, social affairs, family life, hobbies, CDR= 0.5. The mild dementia group (mild AD): using CDR to measure subjects' memory, direction, judgment and problem solving skills, social affairs, family life hobbies CDR=1.

Exclusion criteria

Exclusion criteria: 1. Severe vision or/and hearing impairment, can not complete cognitive function tests; 2. Anxiety, depression, severe insomnia recently; 3. cognitive dysfunction caused by Lack of folate, vitamin B12, thyroid disease, severe cardiopulmonary, liver, kidney, and other diseases of the nervous system?diseases (Lewy body dementiaCorticobasal ganglion degenerationHuntington's choreaProgressive supranuclear palsy; 4. Alcohol or drug dependence, a history of severe head injury; 5. past medical history of cerebrovascular disease (such as ischemic cerebral apoplexy, cerebral hemorrhage, moderate or severe leukoaraisosis, etc.); 6. Intracranial infection, viral encephalitis, CJD, AIDS, neurosyphilis); 7. The subjects refused to participate the trial.

Design outcomes

Primary

MeasureTime frame
Time;Numbers of Errors;disturbance variable;

Countries

China

Contacts

Public ContactYujuan Li

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

yujuan_04@aliyun.com+86 15918734156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026